库普罗托斯菌群可以预测低度质瘤的预后和免疫疗法反应
Wenjun Zhu1, Ziqi Chen1, Min Fu1
1Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Apoptosis : an international journal on programmed cell death
|September 15, 2023
概括
细胞死亡形式的cuprotosis会影响低度质瘤 (LGG) 患者的治疗结果. 一个新的预后特征预测了LGG的存活率和免疫治疗反应,有助于新的治疗开发.
科学领域:
- 在瘤学瘤学.
- 细胞死亡研究 细胞死亡研究
- 基因组学就是基因组学.
背景情况:
- 库普罗托斯是一种新兴的细胞死亡途径,在低级质瘤 (LGG) 中存在着尚未探索的意义.
- 了解cuprotosis的作用对于改善LGG患者的预后和治疗策略至关重要.
研究的目的:
- 调查LGG中与cuprotosis相关的基因的预后价值.
- 为LGG患者开发和验证基于cuprotosis的预后签名.
主要方法:
- 基于LGG患者18个与cuprotosis相关的基因的聚类分析.
- 鉴定差异表达基因 (DEGs) 和LASSO回归,以开发特征.
- 在多个队列中验证预后签名和名录;功能实验.
主要成果:
- 确定了两个不同的LGG患者群 (A和B),A群显示出更好的预后.
- 与cuprotosis相关的预后签名准确地将患者分为高风险和低风险组,具有显著的生存差异.
- 该签名在多个验证队列中证明了预测可靠性,并表明了对高风险患者的潜在免疫治疗益处.
结论:
- 杯症在LGG患者预后中起着重要作用.
- 开发的预后特征是LGG的结果和免疫治疗反应的可靠预测指标.
- 针对特征基因TNFRSF11B,抑制了LGG细胞的增殖和迁移,表明了治疗潜力.
相关概念视频
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
01:27Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K